Compare · head to head
Aclaris Therapeutics vs Regeneron Pharmaceuticals
Regeneron Pharmaceuticals ranks higher overall — 360 rank 83 vs 28.
Regeneron Pharmaceuticals leads on Value (71 vs 42), Quality (56 vs 32) and Safety (64 vs 45). Aclaris Therapeutics leads on Sentiment (62 vs 49). The two are close on Growth.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Biotechnology |
| Size | Small | Large |
| ISIN | US00461U1051 | US75886F1075 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 28 | 83 |
| Value | 42 | 71 |
| Quality | 32 | 56 |
| Growth | 45 | 45 |
| Safety | 45 | 64 |
| Sentiment | 62 | 49 |
| Quality details | ||
| Profitability | 19 | 61 |
| Cash Truth | 46 | 51 |
Aclaris Therapeutics vs Nurix TherapeuticsAclaris Therapeutics vs Syndax PharmaceuticalsAclaris Therapeutics vs XencorAclaris Therapeutics vs Spero TherapeuticsAdd a third stock →
Full analyses: Aclaris Therapeutics · Regeneron Pharmaceuticals
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100